Health
Pfizer Dodges Challenge to Its Board in Fight With Starboard
- Starboard has around $1 billion stake and has criticized CEO
- Deadline passed for nominating board members for this year
This article is for subscribers only.
Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter.
Starboard did not nominate any directors to Pfizer’s board ahead of a Jan. 25 deadline for the company’s annual meeting in April, according to the people.